Posted by Michael Wonder on 02 Jul 2024
FDA approves treatment for adults with Alzheimer’s disease
2 July 2024 - The US FDA has approved Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease.
The efficacy of Kisunla was evaluated in a double-blind, placebo-controlled, parallel-group study in patients with Alzheimer’s disease.
